|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 25, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash from operating activities: | |||||
| Depreciation | |||||
| Amortization of intangibles | |||||
| Expense associated with share-based and grant compensation arrangements | |||||
| Deferred income taxes | |||||
| Unrealized gain on investments and other | |||||
| Impairment of investments | |||||
| Equity in (earnings) loss of investee | |||||
| Net loss (gain) loss on sale, disposition and impairment of assets | |||||
| Impairment of goodwill and other intangibles | |||||
| Gain from reduction of estimated earnout liability | |||||
| Changes in: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Accounts payable and cash overdraft | |||||
| Accrued liabilities and other | |||||
| Net cash from operating activities | |||||
| Cash flows used in investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Purchase and dissolution of remaining noncontrolling interest in subsidiary | |||||
| Acquisitions and purchases of noncontrolling interest, net of cash received | |||||
| Purchases of investments | |||||
| Proceeds from sale of investments | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows used in financing activities: | |||||
| Borrowings under revolving credit facilities | |||||
| Repayments under revolving credit facilities | |||||
| Repayments of debt | |||||
| Repayment of debt on behalf of investee | |||||
| Contingent consideration payments and other | |||||
| Proceeds from issuance of common stock | |||||
| Dividends paid to shareholders | |||||
| Distributions to noncontrolling interest | |||||
| Purchase of remaining noncontrolling interest of subsidiary | |||||
| Payments to taxing authorities in connection with shares directly withheld from employees | |||||
| Repurchase of common stock | |||||
| Other | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net change in cash and cash equivalents | |||||
| Cash, cash equivalents, and restricted cash, beginning of period | |||||
| Cash, cash equivalents, and restricted cash, end of period | |||||
Loading...